1 / 20

Amniotic fluid

Amniotic fluid. Normal & abnormal. Dr. Abdalla H. Alsadig MD. IMPORTANT TOPICS. Amniotic fluid function Clinical importance of AF Volume and composition Amniotic fluid abnormalities. Amniotic fluid function:. Allow room for fetal growth, movement and development.

hoshi
Download Presentation

Amniotic fluid

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Amniotic fluid Normal & abnormal Dr. Abdalla H. Alsadig MD

  2. IMPORTANT TOPICS • Amniotic fluid function • Clinical importance of AF • Volume and composition • Amniotic fluid abnormalities

  3. Amniotic fluid function: • Allow room for fetal growth, movement and development. • Ingestion into GIT→ growth and maturation. • Fetal pulmonary development (20 weeks). • Protects the fetus from trauma. • Maintains temperature. • Contains antibacterial activity. • Aids dilatation of the cervix during labour.

  4. Clinical importance of AF: • Screening for fetal malformation(serum α-fetoprotien). • Assessment of fetal well-being(amniotic fluid index). • Assessment of fetal lung maturity(L/S ratio). • Diagnosis and follow up of labour. • Diagnosis of PROM(ferning test).

  5. Amniotic fluid formation and composition: • First & early second trimester : Amount is 5-50 ml & arises from: - ultrafiltrate of Maternal plasma through the vascularized uterine decidua (in early pregnancy). - Transudation of fetal plasma through the fetal skin & umbilical cord (up to 20 weeks' gestation). * It is iso-osmolar with fetal & maternal plasma, though it is devoid of proteins.

  6. Volume and composition • From 20 weeks up to term (mainly - fetal urine): At 18th week, the fetus voids 7-14ml/day; at term fetal kidneys secretes 600-700ml of urine/day into AF. - Fetal respiratory tract secretes 250ml/day into AF. - Fluid transfers across the placenta. - Fetal oro-nasal secretions. • Secretion is controlled by: - Fetal swallowing at term removes 500ml/day. - Reabsorption into maternal plasma (osmotic gradient). • AF constituents: - urea, creatinine & uric acid + desquamated fetal cells, vernix, lanugo hair & others→ hypo-osmolar amniotic fluid….

  7. Amniotic fluid volume : • About 500 mls enter and leave the amniotic sac each hour. • gradual ↑ up to 36 weeks toaround 600 to 1000 ml then↓ after that. • The normal range is wide but the approximate volumes are: - 500 ml at 18 weeks - 800 ml at 34 weeks. - 600 ml at term.

  8. Amniotic fluid volume assessment • Clinical assessment is unreliable. • Objective assessment depends on U/S to measure: - deepest vertical pool (DVP). - Amniotic fluid index (AFI). It is a total of the DVPs in each four quadrants of the uterus. it is a more sensitive indicator of AFV throughout pregnancy.

  9. Amniotic fluid abnormalities • Oligohydramnios: Defined as reduced amniotic fluid i.e.amniotic fluid index of 5 cm orless or the deepest vertical pool < 2 cm. • Polyhydramnios: Defined as excessive amount of amniotic fluid of 2000 ml or more (AFI of > 25 cm or the deepest vertical pool of > 8 cm) .

  10. 1. Fetal causes: * Renal cause (57%): - Renal agenesis (Potter’s syndrome). - polycystic kidney. - Urethral obstruction (atresia/posterior urethral valve). * Fetal growth restriction. * Fetal death. * Postterm pregnancy. * Preterm premature rupture membranes Causes of oligohydramnios:

  11. Causes of oligohydramnios: 2. Maternal causes: • Uteroplacental insufficiency. • Preeclampsia. 3. Placental causes: • twin-twin transfusion. 4. Drug causes: Prostaglandin synthase inhibitor as NSAID. • 5. Idiopathic

  12. In early pregnancy: Amniotic adhesions or bands→ amputation/death. Pressure deformities (club feet). Pulmonary hypoplasia: - Thoracic compression. - No breathing movement. - No amniotic fluid retain. Flattened face. Postural deformities. Complications of oligohydramnios:

  13. In late pregnancy: • Fetal growth restriction. • Placental abruption. • Preterm labour. • Fetal distress. • Fetal death. • Meconium aspiration. • Labour induction/CS.

  14. Oligohydramnios: • Diagnosis: - Fundal > date. - AF I < 5CM , DVP < 2. • IUGR: abdominal circumference < 10th centile. • Doppler abnormalities • Congenital fetal anomalies. • Management: • Treat the cause (pprom, preeclampsia). • Assess fatal wellbeing (U/S/CTG/Doppler/BPP). • Vesicoamniotic shunting (urethral obstruction). • Amnioinfusion (no↓ in fetal death).

  15. Polyhydramnios

  16. Polyhydramnios • types 1. Mild hydramnios (80%): a pocket of amniotic fluid measuring 8 to 11 cm. 2. moderate hydramnios (15%): a pocket of amniotic fluid measuring 12 to 15 cm. 3. Severe hydramnios (5%) - twin-twin transfusion syndrome : a pocket of amniotic fluid measuring 16 cm or more.

  17. Fetal malformation: - GIT: esophageal/duodenal atresia, tracheoesophageal fistula. - CNS: anencephaly (↓swallowing, exposed meninges, no antidiuretic hormone). Twin-twin transfusion → fetal polyuria. Hydrops fetalis: congestive heart failure, severe anaemia or hypoproteinemia → placental transudation diabetes mellitus (osmotic diuresis). Idiopathic. Causes of polyhydramnios

  18. Symptoms: - dyspnea. - edema. - abdominal distention - preterm labour. Abdominal examination: - ↑uterus than expected. - difficult to palpate fetal parts. - difficult to hear fetal heart sound. - ballotable fetus. Ultrasound: - excessive amniotic fluid. - fetal abnormalities. diagnosis of polyhydramnios

  19. management • Minor degrees: no treatment. • Bed rest, diuretics, water and salt restriction: ineffective. • Hospitalization: dyspnea, abdominal pain or difficult ambulation. • Endomethacin therapy: . - impairs lung liquid production/enhances absorption. - ↓fluid movement across fetal membranes. * complications: premature closure of ductus arteriosus, impairment of renal function, and cerebral vasoconstriction. So not used after 35 weeks • Amniocentesis: to relieve maternal distress and to test for fetal lung maturity. Complications: ruptured membrane, chorioamnionitis, placental abruption, preterm labour.

  20. Thanks

More Related